-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VnTgJtbN0luldiqiThENffhvBB6Iw3pd4W4FBNZxiAU6RE2sBD9gt5aoufEV4P0P 2TZxQkT54mrEm886MvW0zQ== 0000891836-02-000407.txt : 20020815 0000891836-02-000407.hdr.sgml : 20020815 20020815100340 ACCESSION NUMBER: 0000891836-02-000407 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20020815 GROUP MEMBERS: ANDREW H. TISCH GROUP MEMBERS: BONNIE J. TISCH GROUP MEMBERS: FELIX J. BAKER GROUP MEMBERS: JAMES S. TISCH GROUP MEMBERS: JULIAN C. BAKER GROUP MEMBERS: THOMAS J. TISCH SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE GENOMICS INC CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-45040 FILM NUMBER: 02739007 BUSINESS ADDRESS: STREET 1: 3160 PORTER DR CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 6508550555 MAIL ADDRESS: STREET 1: 3160 PORTER DRIVE CITY: PALO ALTO STATE: CA ZIP: 94304 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: TISCH DANIEL R CENTRAL INDEX KEY: 0001111794 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 500 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2129356655 MAIL ADDRESS: STREET 1: 500 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 SC 13D 1 sc0239.txt SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13D-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13D-2(a) INCYTE GENOMICS, INC. - -------------------------------------------------------------------------------- (Name of Issuer) COMMON STOCK, $0.001 PER SHARE - -------------------------------------------------------------------------------- (Title of Class of Securities) 45337C-10-2 --------------------------------------------------------------------- (CUSIP Number) BARRY L. BLOOM 655 MADISON AVENUE 8TH FLOOR NEW YORK, NY 10021 (212) 521-2930 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) AUGUST 5, 2002 --------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. [X] NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 20 Pages SCHEDULE 13D - ---------------------------------- ------------------------------------ CUSIP NO. 45337C-10-2 PAGE 2 OF 20 PAGES - ---------------------------------- ------------------------------------ - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS Andrew H. Tisch - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [_] (b) [X] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (See Instructions) PF - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER -0- ------------------------------------------------------------ NUMBER OF 8 SHARED VOTING POWER SHARES BENEFICIALLY 3,982,135 OWNED BY ------------------------------------------------------------ EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON WITH -0- ------------------------------------------------------------ 10 SHARED DISPOSITIVE POWER 3,982,135 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,982,135 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [_] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.8% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See Instructions) IN - -------------------------------------------------------------------------------- SCHEDULE 13D - ---------------------------------- ------------------------------------ CUSIP NO. 45337C-10-2 PAGE 3 OF 20 PAGES - ---------------------------------- ------------------------------------ - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS Daniel R. Tisch - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [_] (b) [X] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (See Instructions) PF - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER 52,877 ------------------------------------------------------------ NUMBER OF 8 SHARED VOTING POWER SHARES BENEFICIALLY 3,982,580 OWNED BY ------------------------------------------------------------ EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON WITH 52,877 ------------------------------------------------------------ 10 SHARED DISPOSITIVE POWER 3,982,580 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,035,457 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [_] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.9% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See Instructions) IN - -------------------------------------------------------------------------------- SCHEDULE 13D - ---------------------------------- ------------------------------------ CUSIP NO. 45337C-10-2 PAGE 4 OF 20 PAGES - ---------------------------------- ------------------------------------ - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS James S. Tisch - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [_] (b) [X] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (See Instructions) PF - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER -0- ------------------------------------------------------------ NUMBER OF 8 SHARED VOTING POWER SHARES BENEFICIALLY 3,982,135 OWNED BY ------------------------------------------------------------ EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON WITH -0- ------------------------------------------------------------ 10 SHARED DISPOSITIVE POWER 3,982,135 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,982,135 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [_] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.8% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See Instructions) IN - -------------------------------------------------------------------------------- SCHEDULE 13D - ---------------------------------- ------------------------------------ CUSIP NO. 45337C-10-2 PAGE 5 OF 20 PAGES - ---------------------------------- ------------------------------------ - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS Thomas J. Tisch - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [_] (b) [X] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (See Instructions) PF - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER -0- ------------------------------------------------------------ NUMBER OF 8 SHARED VOTING POWER SHARES BENEFICIALLY 4,182,135 OWNED BY ------------------------------------------------------------ EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON WITH -0- ------------------------------------------------------------ 10 SHARED DISPOSITIVE POWER 4,182,135 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,182,135 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [_] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 6.1% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See Instructions) IN - -------------------------------------------------------------------------------- SCHEDULE 13D - ---------------------------------- ------------------------------------ CUSIP NO. 45337C-10-2 PAGE 6 OF 20 PAGES - ---------------------------------- ------------------------------------ - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS Bonnie J. Tisch - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [_] (b) [X] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (See Instructions) PF - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER -0- ------------------------------------------------------------ NUMBER OF 8 SHARED VOTING POWER SHARES BENEFICIALLY 444 OWNED BY ------------------------------------------------------------ EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON WITH -0- ------------------------------------------------------------ 10 SHARED DISPOSITIVE POWER 444 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 444 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [_] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.1% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See Instructions) IN - -------------------------------------------------------------------------------- SCHEDULE 13D - ---------------------------------- ------------------------------------ CUSIP NO. 45337C-10-2 PAGE 7 OF 20 PAGES - ---------------------------------- ------------------------------------ - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS Julian C. Baker - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [_] (b) [X] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (See Instructions) PF - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER 27,917 ------------------------------------------------------------ NUMBER OF 8 SHARED VOTING POWER SHARES BENEFICIALLY 1,900,567 OWNED BY ------------------------------------------------------------ EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON WITH 27,917 ------------------------------------------------------------ 10 SHARED DISPOSITIVE POWER 1,900,567 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,928,484 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [_] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 2.9% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See Instructions) IN - -------------------------------------------------------------------------------- SCHEDULE 13D - ---------------------------------- ------------------------------------ CUSIP NO. 45337C-10-2 PAGE 8 OF 20 PAGES - ---------------------------------- ------------------------------------ - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS Felix J. Baker - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [_] (b) [X] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (See Instructions) PF - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER -0- ------------------------------------------------------------ NUMBER OF 8 SHARED VOTING POWER SHARES BENEFICIALLY 1,900,567 OWNED BY ------------------------------------------------------------ EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON WITH -0- ------------------------------------------------------------ 10 SHARED DISPOSITIVE POWER 1,900,567 - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,900,567 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [_] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 2.8% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See Instructions) IN - -------------------------------------------------------------------------------- ITEM 1. SECURITY AND ISSUER. This statement on Schedule 13D relates to the common stock, par value $0.001 per share (the "Common Stock") of Incyte Genomics, Inc., a Delaware corporation (the "Company"). The principal executive offices of the Company are located at 3160 Porter Drive, Palo Alto, California 94304. ITEM 2. IDENTITY AND BACKGROUND. This statement is being filed by Andrew H. Tisch, Daniel R. Tisch, James S. Tisch, Thomas J. Tisch, Bonnie J. Tisch, Julian C. Baker and Felix J. Baker (each, a "Reporting Person"). Each of the Reporting Persons is a United States citizen. Set forth below is certain information with respect to each of the Reporting Persons: NAME BUSINESS ADDRESS PRESENT PRINCIPAL OCCUPATION - ---- ---------------- ---------------------------- Andrew H. Tisch 667 Madison Avenue Member, Management Committee, New York, NY 10021 Loews Corporation (a public company primarily engaged in insurance and tobacco) Daniel R. Tisch c/o Mentor Partners, L.P. General Partner, Mentor 499 Park Avenue Partners, L.P. (a partnership New York, NY 10022 engaged in investment activities) James S. Tisch 667 Madison Avenue President and Chief Operating New York, NY 10021 Officer, Loews Corporation (a public company primarily engaged in insurance and tobacco) Thomas J. Tisch 667 Madison Avenue Managing Partner of FLF New York, NY 10021 Associates and Manager of Four Partners (partnerships engaged in investment activities) Bonnie J. Tisch c/o Mentor Partners, L.P. Wife of Daniel R. Tisch 499 Park Avenue New York, NY 10022 Page 9 of 20 Pages NAME BUSINESS ADDRESS PRESENT PRINCIPAL OCCUPATION - ---- ---------------- ---------------------------- Julian C. Baker 655 Madison Avenue Managing Member, Baker Bros. New York, NY 10021 Capital (GP), LLC, Baker Biotech Capital (GP), LLC, Baker Biotech Capital II (GP), LLC and Baker/Tisch Capital (GP), LLC (manager of partnerships engaged in investment activities) Felix J. Baker 655 Madison Avenue Managing Member, Baker Bros. New York, NY 10021 Capital (GP), LLC, Baker Biotech Capital (GP), LLC, Baker Biotech Capital II (GP), LLC and Baker/Tisch Capital (GP), LLC (manager of partnerships engaged in investment activities) During the last five years, none of the Reporting Persons has been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors), and none of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction resulting in his being subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws, or finding any violations with respect to such loss. ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. The funds used to purchase the shares of Common Stock reported in the second table under Item 5 below were provided from the available working capital of the entity indicated as making the purchase. The aggregate price of each purchase is included in the second table under Item 5 below. ITEM 4. PURPOSE OF TRANSACTION. The Reporting Persons have acquired the shares of Common Stock referred to in Item 5 solely for investment. Each Reporting Person expects to review his investment position from time to time and may, depending on market conditions or other factors, increase or decrease such investment position. Whether a Reporting Person purchases any additional shares of Common Stock or disposes of any shares of Common Stock and the amount and timing of any such transactions will depend upon each Reporting Person's individual continuing assessment of pertinent factors, including the availability of shares for purchase at particular price levels, the Company's business and prospects, other business investment opportunities available to the particular Reporting Person, economic conditions, market conditions, the attitudes and actions of the Board of Directors and management of the Company, the availability and nature of opportunities to dispose of the particular Reporting Person's interest in the Company and other plans and requirements of the particular Reporting Person. Page 10 of 20 Pages Julian C. Baker is a director of the Company, and Felix J. Baker attends and observes meetings of the Company's board of directors. At the present time, the Reporting Persons do not have any plans or proposals with respect to any extraordinary corporate transaction involving the Company or any sale of its assets or any change in its Board of Directors, management, capitalization, dividend strategy, charter or by-laws, or any other change in its business or corporate structure or with respect to the delisting or deregistration of any of its securities including, without limitation, those matters described in subparagraphs (a) though (j) of Item 4 of Schedule 13D. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. Because of certain business and family relationships among the Reporting Persons, they are filing as if they constitute a group solely for informational purposes. By signing this statement, each Reporting Person agrees that this Statement is filed on his or her behalf. The filing of this statement is not an admission by any Reporting Person that such Reporting Person and any other Reporting Person or Reporting Persons constitute a "group" for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, or Rule 13d-5 thereunder. Each Reporting Person disclaims beneficial ownership of, or pecuniary interest in, any shares of Common Stock owned by any other Reporting Person, except to the extent that beneficial ownership or pecuniary interest is expressly reported herein. Set forth in the table below is the aggregate number of shares of Common Stock owned by each of the following, together with the percentage of outstanding shares of Common Stock that such owner ownership represents. Page 11 of 20 Pages AMOUNT AND NATURE OF PERCENT OF CLASS NAME OF BENEFICIAL OWNER BENEFICIAL OWNERSHIP OUTSTANDING (1) - ------------------------------------ ----------------------- ----------------- Four Partners 3,522,353 5.2% Four-Fourteen Partners, LLC 200,000 0.3% Damial Foundation 52,877 0.1% Andrew H. Tisch (2) 459,782 0.7% Daniel R. Tisch (2) 459,782 0.7% James S. Tisch (2) 459,782 0.7% Thomas J. Tisch (2) 459,782 0.7% Bonnie J. Tisch 444 0.0% Baker/Tisch Investments, L.P. 278,593 0.4% Baker Bros. Investments, L.P. 147,964 0.2% Baker Bros. Investments II, L.P. 66,040 0.1% Baker Biotech Fund I, L.P. 886,855 1.3% Baker Biotech Fund II, L.P. 463,457 0.7% FBB Associates 55,658 0.1% Julian C. Baker 27,917(3) 0.1% Total 7,543,286 11.0% (1) The ownership percentages set forth in the table above are based upon 67,529,022 shares of Common Stock outstanding, as reported on the Company's Form 10-Q for the fiscal quarter ended June 30, 2002, plus the shares that each person listed has the right to acquire upon conversion of 5.5% Convertible Subordinated Notes due 2007 at the presently applicable conversion price of $67.4195 or exercise of non-qualified stock options. (2) Includes shares held by the Reporting Person in his individual capacity or by a trust in which the Reporting Person is the trustee or managing trustee and has voting or investment control over securities held by such trust. (3) Represents shares that may be acquired upon exercise of non-qualified stock options. Each person listed above has sole power to vote or direct the vote of and to dispose or direct the disposition of the securities listed after such person's name, except as follows: (1) By virtue of their status as managing trustees of the trusts that are the general partners of Four Partners, a New York general partnership, Andrew H. Tisch, Daniel R. Tisch, James S. Tisch and Thomas J. Tisch may be deemed to have shared beneficial ownership of securities owned by Four Partners and shared power to vote or direct the vote of and to dispose or direct the disposition of such securities. Page 12 of 20 Pages (2) By virtue of his status as manager of Four-Fourteen Partners, LLC, Thomas J. Tisch may be deemed to be the beneficial owner of securities owned by Four-Fourteen Partners, LLC and to have power to vote or direct the vote of and to dispose or direct the disposition of securities owned by Four-Fourteen Partners, LLC. (3) Daniel R. Tisch may be deemed to be the beneficial owner of securities owned by Damial Foundation, a Delaware not-for-profit corporation, and to have power to vote or direct the vote of and to dispose or direct the disposition of securities owned by Damial Foundation. (4) Daniel R. Tisch may be deemed to share the power to vote or direct the vote of and to dispose or direct the disposition of securities owned by his wife, Bonnie J. Tisch, as custodian for their son, Michael J. Tisch. (5) Julian C. Baker and Felix J. Baker, by virtue of their control of entities that have the power to control the investment decisions of Baker/Tisch Investments, L.P., Baker Bros. Investments, L.P., Baker Bros. Investments II, L.P., Baker Biotech Fund I, L.P. and Baker Biotech Fund II, L.P., may each be deemed to be the beneficial owners of securities owned by such entities and may be deemed to have shared power to vote or direct the vote of and to dispose or direct the disposition of such securities. Julian C. Baker and Felix J. Baker are also the sole partners of FBB Associates, a general partnership, and as such may be deemed to be beneficial owners of securities owned by FBB Associates and to have shared power to vote or direct the vote of and to dispose or direct the disposition of such securities. The following purchases of Common Stock were effected by the entities noted below during the 60 days preceding the date hereof. None of the Reporting Persons has effected any other transactions in Common Stock during the 60 days preceding the date hereof. The following transactions were effected through NASDAQ. NUMBER OF PRICE/ AGGREGATE NAME DATE SHARES SHARE AMOUNT - ------------------------------- ---------- ----------- --------- ---------- Four Partners 07/10/02 14,000 $5.37 $75,506 Four Partners 07/11/02 48,333 $5.60 $271,453 Four Partners 07/16/02 5,100 $6.23 $31,898 Four Partners 07/18/02 20,000 $6.14 $123,230 Four Partners 07/24/02 12,450 $5.65 $70,601 Four Partners 07/24/02 26,600 $5.93 $158,395 Four Partners 07/29/02 16,000 $5.90 $94,707 Four Partners 07/30/02 36,600 $5.88 $216,064 Page 13 of 20 Pages NUMBER OF PRICE/ AGGREGATE NAME DATE SHARES SHARE AMOUNT - ------------------------------- ---------- ----------- --------- ---------- Four Partners 07/31/02 22,200 $6.00 $133,633 Four Partners 08/01/02 56,700 $5.94 $338,108 Four Partners 08/02/02 19,450 $5.82 $113,569 Four Partners 08/05/02 37,000 $5.86 $217,623 Four Partners 08/06/02 23,300 $6.00 $140,247 Four Partners 08/07/02 115,900 $5.96 $693,488 Baker Biotech Fund I, L.P. 07/10/02 12,320 $5.37 $66,446 Baker Biotech Fund I, L.P. 07/11/02 42,530 $5.60 $238,861 Baker Biotech Fund I, L.P. 07/16/02 4,500 $6.23 $28,145 Baker Biotech Fund I, L.P. 07/18/02 17,550 $6.14 $108,134 Baker Biotech Fund I, L.P. 07/24/02 10,950 $5.65 $62,095 Baker Biotech Fund I, L.P. 07/24/02 23,400 $5.93 $139,340 Baker Biotech Fund I, L.P. 07/29/02 13,800 $5.90 $81,685 Baker Biotech Fund I, L.P. 07/30/02 32,200 $5.88 $190,089 Baker Biotech Fund I, L.P. 07/31/02 19,400 $6.00 $116,778 Baker Biotech Fund I, L.P. 08/01/02 49,000 $5.94 $292,192 Baker Biotech Fund I, L.P. 08/02/02 16,800 $5.82 $98,095 Baker Biotech Fund I, L.P. 08/05/02 32,100 $5.86 $188,803 Baker Biotech Fund I, L.P. 08/06/02 20,150 $6.00 $121,287 Baker Biotech Fund I, L.P. 08/07/02 100,100 $5.96 $598,948 Baker Biotech Fund I, L.P. 08/08/02 96,000 $5.99 $577,286 Baker Biotech Fund I, L.P. 08/09/02 300 $5.75 $1,731 Baker Biotech Fund II, L.P. 07/10/02 11,480 $5.37 $61,915 Baker Biotech Fund II, L.P. 07/11/02 39,630 $5.60 $222,574 Baker Biotech Fund II, L.P. 07/16/02 4,150 $6.23 $25,956 Baker Biotech Fund II, L.P. 07/18/02 16,250 $6.14 $100,124 Page 14 of 20 Pages NUMBER OF PRICE/ AGGREGATE NAME DATE SHARES SHARE AMOUNT - ------------------------------- ---------- ----------- --------- ---------- Baker Biotech Fund II, L.P. 07/24/02 10,150 $5.65 $57,559 Baker Biotech Fund II, L.P. 07/24/02 21,700 $5.93 $129,217 Baker Biotech Fund II, L.P. 07/29/02 12,800 $5.90 $75,766 Baker Biotech Fund II, L.P. 07/30/02 29,850 $5.88 $176,216 Baker Biotech Fund II, L.P. 07/31/02 18,000 $6.00 $108,351 Baker Biotech Fund II, L.P. 08/01/02 46,747 $5.94 $278,757 Baker Biotech Fund II, L.P. 08/02/02 16,050 $5.82 $93,716 Baker Biotech Fund II, L.P. 08/05/02 30,600 $5.86 $179,980 Baker Biotech Fund II, L.P. 08/06/02 19,200 $6.00 $115,569 Baker Biotech Fund II, L.P. 08/07/02 95,500 $5.96 $571,424 Baker Biotech Fund II, L.P. 08/08/02 91,600 $5.99 $550,827 Baker Biotech Fund II, L.P. 08/09/02 250 $5.75 $1,443 Baker Bros. Investments, L.P. 07/10/02 1,120 $5.37 $6,041 Baker Bros. Investments, L.P. 07/11/02 3,870 $5.60 $21,735 Baker Bros. Investments, L.P. 07/16/02 450 $6.23 $2,815 Baker Bros. Investments, L.P. 07/18/02 1,750 $6.14 $10,783 Baker Bros. Investments, L.P. 07/24/02 1,100 $5.65 $6,238 Baker Bros. Investments, L.P. 07/24/02 2,300 $5.93 $13,696 Baker Bros. Investments, L.P. 07/29/02 1,400 $5.90 $8,287 Baker Bros. Investments, L.P. 07/30/02 3,200 $5.88 $18,891 Baker Bros. Investments, L.P. 07/31/02 1,950 $6.00 $11,738 Baker Bros. Investments, L.P. 08/01/02 5,000 $5.94 $29,816 Baker Bros. Investments, L.P. 08/02/02 1,700 $5.82 $9,926 Baker Bros. Investments, L.P. 08/05/02 3,300 $5.86 $19,410 Baker Bros. Investments, L.P. 08/06/02 2,050 $6.00 $12,339 Baker Bros. Investments, L.P. 08/07/02 10,150 $5.96 $60,733 Page 15 of 20 Pages NUMBER OF PRICE/ AGGREGATE NAME DATE SHARES SHARE AMOUNT - ------------------------------- ---------- ----------- --------- ---------- Baker Bros. Investments, L.P. 08/08/02 9,700 $5.99 $58,330 Baker Bros. Investments II, L.P. 07/10/02 1,120 $5.37 $6,041 Baker Bros. Investments II, L.P. 07/11/02 3,870 $5.60 $21,735 Baker Bros. Investments II, L.P. 07/16/02 450 $6.23 $2,815 Baker Bros. Investments II, L.P. 07/18/02 1,800 $6.14 $11,091 Baker Bros. Investments II, L.P. 07/24/02 1,100 $5.65 $6,238 Baker Bros. Investments II, L.P. 07/24/02 2,400 $5.93 $14,291 Baker Bros. Investments II, L.P. 07/29/02 1,400 $5.90 $8,287 Baker Bros. Investments II, L.P. 07/30/02 3,250 $5.88 $19,186 Baker Bros. Investments II, L.P. 07/31/02 1,950 $6.00 $11,738 Baker Bros. Investments II, L.P. 08/01/02 5,100 $5.94 $30,412 Baker Bros. Investments II, L.P. 08/02/02 1,750 $5.82 $10,218 Baker Bros. Investments II, L.P. 08/05/02 3,300 $5.86 $19,410 Baker Bros. Investments II, L.P. 08/06/02 2,100 $6.00 $12,640 Baker Bros. Investments II, L.P. 08/07/02 10,450 $5.96 $62,528 Baker Bros. Investments II, L.P. 08/08/02 10,000 $5.99 $60,134 Baker/Tisch Investments, L.P. 07/10/02 1,960 $5.37 $10,571 Baker/Tisch Investments, L.P. 07/11/02 6,767 $5.60 $38,006 Baker/Tisch Investments, L.P. 07/16/02 650 $6.23 $4,065 Baker/Tisch Investments, L.P. 07/18/02 2,650 $6.14 $16,328 Baker/Tisch Investments, L.P. 07/24/02 1,650 $5.65 $9,357 Baker/Tisch Investments, L.P. 07/24/02 3,500 $5.93 $20,842 Baker/Tisch Investments, L.P. 07/29/02 2,100 $5.90 $12,430 Baker/Tisch Investments, L.P. 07/30/02 4,900 $5.88 $28,927 Baker/Tisch Investments, L.P. 07/31/02 3,000 $6.00 $18,059 Baker/Tisch Investments, L.P. 08/01/02 7,600 $5.94 $45,320 Page 16 of 20 Pages NUMBER OF PRICE/ AGGREGATE NAME DATE SHARES SHARE AMOUNT - ------------------------------- ---------- ----------- --------- ---------- Baker/Tisch Investments, L.P. 08/02/02 2,600 $5.82 $15,181 Baker/Tisch Investments, L.P. 08/05/02 4,973 $5.86 $29,250 Baker/Tisch Investments, L.P. 08/06/02 3,123 $6.00 $18,798 Baker/Tisch Investments, L.P. 08/07/02 15,500 $5.96 $92,744 Baker/Tisch Investments, L.P. 08/08/02 14,900 $5.99 $89,600 Baker/Tisch Investments, L.P. 08/09/02 50 $5.75 $289 Page 17 of 20 Pages ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER. None of the Reporting Persons has any contracts, arrangements or understandings with any other Reporting Person or with any other person with respect to the securities of the Company. ITEM 7. MATERIAL TO BE FILED AS EXHIBITS. Exhibit 1. Agreement regarding the joint filing of this statement. Page 18 of 20 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. August 15, 2002 By: /s/ Andrew H. Tisch ------------------------------------- Andrew H. Tisch By: /s/ Daniel R. Tisch ------------------------------------- Daniel R. Tisch By: /s/ James S. Tisch ------------------------------------- James S. Tisch By: /s/ Thomas J. Tisch ------------------------------------- Thomas J. Tisch By: /s/ Bonnie J. Tisch ------------------------------------- Bonnie J. Tisch By: /s/ Julian C. Baker ------------------------------------- Julian C. Baker By: /s/ Felix J. Baker ------------------------------------- Felix J. Baker Page 19 of 20 Pages EX-99.1 3 ex-99.txt EXHIBIT 1: JOINT FILING AGREEMENT EXHIBIT 1 AGREEMENT In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13D relating to the Common Stock, par value $0.001 per share, of Incyte Genomics, Inc., and such other amendments as may be filed by them hereafter, are being filed with the Securities and Exchange Commission on behalf of each of them. August 15, 2002 By: /s/ Andrew H. Tisch ------------------------------------- Andrew H. Tisch By: /s/ Daniel R. Tisch ------------------------------------- Daniel R. Tisch By: /s/ James S. Tisch ------------------------------------- James S. Tisch By: /s/ Thomas J. Tisch ------------------------------------- Thomas J. Tisch By: /s/ Bonnie J. Tisch ------------------------------------- Bonnie J. Tisch By: /s/ Julian C. Baker ------------------------------------- Julian C. Baker By: /s/ Felix J. Baker ------------------------------------- Felix J. Baker Page 20 of 20 Pages -----END PRIVACY-ENHANCED MESSAGE-----